← All articles

Total current articles · 5,232

Harvey Prize

Published

01In brief

Harvey Prize is an annual award presented by the Technion–Israel Institute of Technology in Haifa for outstanding achievements in science, technology, and human health, and for significant contributions to humanity. Its recipients have included scientists across mathematics, physics, and medicine. Jewish scholarship has also been recognized. The 1980 prize was shared by Michael Oser Rabin, Shlomo Dov Goitein, and Efraim Racker. It was established by industrialist and inventor Leo Harvey. The prize has also recognized contributions to peace and society. Its scientific awards have honored theoretical computation and particle physics. They have also recognized cancer treatments and technologies underlying mRNA vaccines.

02Overview

The Harvey Prize recognizes both scientific achievement and contributions to human progress, with award fields encompassing science and technology, human health, and service to humanity.[1] Its scope has also included breakthroughs contributing to peace in the Middle East.[6] The 2014 awards were valued at $75,000 each, while a 2023 account likewise gave the prize value as $75,000.[6][7]

The range of recipients extends beyond laboratory science: Talmud scholar Saul Lieberman received the prize in 1976, while Ronald S. Lauder was selected for an award for outstanding contribution to society in 2019.[3][5] Scientific recipients have included researchers in mathematical logic and fractal geometry.[2][8] Others have worked on nervous-system development and cancer immunotherapy.[9][6] The prize has also honored RNA-based medicine.[1]

03Origins and History

Leo Harvey, an industrialist and inventor who lived from 1887 to 1973, was a devoted supporter of both the Technion and the State of Israel.[1] The establishment year is reported differently: some accounts place it in 1971, while a 2026 report says Harvey established the prize in 1972, the year it was first awarded.[1][10]

Among recipients in the 1970s, Saul Lieberman received the Harvey Prize in 1976, following his receipt of the Israel Prize for Jewish Studies in 1971.[3] A rabbi and Talmud scholar, Lieberman also served for many years as president of the American Academy for Jewish Research.[3] Freeman Dyson received the prize in 1977 for applying mathematical analysis to theoretical physics; his subsequent honors included the Wolf Prize in 1981.[11] Bernard Lewis received the Harvey Prize in 1978, among a broader set of honors that also included recognition from the Hebrew University of Jerusalem and Tel Aviv University.[12]

The 1980 award brought together Michael Oser Rabin, Shlomo Dov Goitein, and Efraim Racker as joint recipients.[2] Rabin's prize was in science and technology, and his research encompassed mathematical logic and the mathematical theory of computation.[2][13] His work in mathematics and computer science included the Miller–Rabin test, an algorithm for determining whether a number is prime.[13]

Robert J. Aumann received the Harvey Prize for science and technology in 1983; his mathematical research included game-theoretic analysis of long-term, repeated interactions.[14] Sydney Brenner received the prize in 1987, with his scientific work encompassing the genetic control of nervous-system development and studies using the nematode Caenorhabditis elegans and the Japanese pufferfish Fugu.[9] Benoit B. Mandelbrot, known for developing fractal geometry and applying it to patterns in nature and other fields, received the science and technology prize in 1989.[8] Richard Karp, whose research concerned theoretical computer science and algorithms, received the prize in 1998.[15]

04Award Fields and Presentation

The awards announced in 2023 distinguished between human health and science and technology: Katalin Karikó, Drew Weissman, and Pieter R. Cullis were named in human health, and Helen Quinn in science and technology.[1] Their presentation was scheduled for June 2024 during the Technion Board of Governors meeting and the institution's centennial celebrations.[1] The health laureates were recognized for research enabling the rapid development and delivery of COVID-19 vaccines, with applications extending to new medicines and gene therapies.[7]

Award years and presentation dates have not always coincided: Weissman's Harvey Prize was awarded for 2021 but received in 2023.[16] The 2019–2020 awards to Joseph DeSimone and Raphael Mechoulam were described as prizes in chemical engineering and medical sciences.[17] As of October 2026, the most recent recipients were David R. Liu and Chad A. Mirkin, recognized for advances in nanotechnology and medicine.[10]

The prize has also recognized achievements outside these scientific fields.[4][5] Mikhail Gorbachev received a Harvey Prize for peace before receiving the Nobel Peace Prize.[4] In 2019, Lauder was scheduled to receive the Harvey Prize for Outstanding Contribution to Society at a Haifa ceremony held as part of the Technion's annual Board of Governors events.[5] His award citation recognized his activities as a philanthropist, diplomat, entrepreneur, and arts patron, together with his commitment to Jewish heritage, Jewish communities worldwide, Israel, and other communities.[5]

05Medical and Biological Research

James P. Allison was announced as a Harvey Prize recipient in 2014 for work involving T-cell development and activation.[6] His research included isolating the T-cell antigen receptor complex protein, and his work at the University of California, Berkeley, during the 1990s led to the clinical development of ipilimumab.[6] By the time of the award announcement, the U.S. Food and Drug Administration had approved the drug for metastatic melanoma.[6]

Karl Deisseroth and Peter Hegemann received the prize in 2016 for research associated with optogenetics, which uses light to control nerve signals in living creatures.[10] Hegemann and Georg Nagel discovered channelrhodopsin, a protein capable of making cells light-sensitive, and Deisseroth conducted subsequent experiments advancing the technique.[10]

The 2019–2020 award recognized Raphael Mechoulam of the Hebrew University for research into the components and mechanisms of the cannabinoid system and their implications for human health.[17] His achievements included isolating THC, mapping its structure, and identifying major components including cannabidiol, or CBD.[17] At the time of the announcement, CBD was increasingly being used for medicinal purposes.[17]

Karikó and Weissman's collaboration addressed an obstacle to RNA-based treatment: inflammatory responses to mRNA molecules.[1] Their development of nucleoside-modified mRNA suppressed those responses and opened the way to RNA-based therapeutics.[1] A 2005 study used synthetic nucleosides to modify RNA, and the resulting technology became a foundational component of the Pfizer/BioNTech and Moderna COVID-19 vaccines in 2020.[16]

Karikó, a biochemist focused on RNA biology, persisted with mRNA research despite academic skepticism about its potential.[1] At the time of the 2023 announcement, she had worked as a professor of neurosurgery at the University of Pennsylvania for 24 years.[1] Weissman, an immunologist studying RNA biology, opened his University of Pennsylvania laboratory in 1997 with a focus on RNA and vaccines.[1]

Cullis's contribution concerned the delivery of therapeutic material into cells: he developed lipid nanoparticles that protect mRNA and transport it into cells, a platform later adapted for RNA-based vaccines.[1] His advances in nanomedicine also encompassed lipid nanoparticle technologies for cancer therapies and gene therapies.[1] Together, the work of Karikó, Weissman, and Cullis enabled the rapid development and delivery of effective COVID-19 vaccines.[1]

Stephen Baylin, Peter Jones, and Andrew Feinberg were selected for the science and technology prize for cancer epigenetics, with its presentation scheduled for June 2025.[18] Their research showed how epigenetic processes, including DNA methylation, affect cell function and cancer development, challenging the view that cancer develops only through genetic mutations.[18] The findings supported diagnostic approaches and treatments based on epigenetic mechanisms.[18]

06Physics, Materials, and Technology

Shoji Nakamura received the 2009 Harvey Prize for science and technology for inventing the blue LED, five years before sharing the 2014 Nobel Prize in Physics for that invention.[4] Blue LEDs made white LED lighting possible for applications including homes, streets, and traffic signals, providing the same amount of light with substantially less energy than earlier lighting technologies.[4]

Reinhard Genzel was named alongside Allison as a 2014 Harvey Prize recipient.[6] Genzel and colleagues in the United States and Germany discovered an object at the center of the galaxy smaller than the Solar System but with a mass three to four million times that of the Sun.[6] His research used advanced infrared instruments to investigate the galactic center, active galactic nuclei, and star formation in high-redshift galaxies.[6]

Joseph DeSimone of Stanford University received the 2019–2020 prize alongside Mechoulam.[17] His contributions spanned materials science, chemistry, polymer science, nanomedicine, and 3D printing.[17] They included using supercritical carbon dioxide to produce fluoropolymers, particle replication in non-wetting templates, and continuous liquid interface production.[17] At the time of the award report, he had published more than 350 scientific articles and held over 200 patents; in 2016, U.S. President Barack Obama had recognized his achievements and leadership in innovative technology.[17]

Helen Quinn's selection recognized theoretical physics research, including her introduction of Peccei–Quinn symmetry with Roberto Peccei.[1] Their proposal addressed the behavior of strong interactions under the combined operations of charge conjugation and parity, and predicted axions, particles that may constitute dark matter.[1] Quinn also worked with Howard Georgi and Steven Weinberg to show how the strong, weak, and electromagnetic interactions might arise from a single force at high energies, a framework known as grand unification.[1]

07Significance

Several Harvey Prize recipients subsequently received Nobel Prizes, including Ada Yonath, Robert J. Aumann, and Nakamura.[4] This pattern has given the Harvey Prize a reputation as a “Nobel predictor.”[7] Published estimates vary: a 2026 account put the proportion at approximately 20%, while a 2023 account said more than 30%.[10][1] Nakamura's recognition for the blue LED provides a specific example of the Technion award preceding Nobel recognition for the same invention.[4] In 2026, Deisseroth and Hegemann, who had received the Harvey Prize in 2016, shared the Nobel Prize in Medicine with Nagel for discoveries concerning light-gated ion channels and optogenetics.[10]

Recipients have also emphasized the prize's recognition of fundamental research.[10] After receiving it in 2016, Deisseroth said, “For this reason, receiving the Harvey Prize is a great honor for me, because it recognizes basic science.”[10] Hegemann called it “among the most important prizes” he had won.[10]

The achievements honored connect fundamental inquiry with practical applications. Allison's research contributed to a cancer drug.[6] The work of Karikó, Weissman, and Cullis underpinned mRNA vaccines.[1] Nakamura's blue LED enabled energy-saving white LED lighting.[4] The prize's record also encompasses Jewish scholarship and support for Jewish communal life through recipients such as Lieberman and Lauder.[3][5]

Sources

  1. 1Ynetnews, COVID vaccine developers among Technion Harvey Prize recipients, accessed on November 9, 2026.
  2. 2Encyclopedia.com, Rabin, Michael Oser, accessed on November 9, 2026.
  3. 3Jewish Virtual Library, Saul Lieberman, accessed on November 9, 2026.
  4. 4Ynet, From the Technion Prize to the Nobel: The Man Who Saw the Light, accessed on November 9, 2026.
  5. 5The Jerusalem Post, Ronald S. Lauder to receive Technion prize, accessed on November 9, 2026.
  6. 6The Jerusalem Post, Technion announces Harvey Prize winners for 2014, accessed on November 9, 2026.
  7. 7Ynet, Vaccine Technology and Particle Research: Harvey Prize Winners at the Technion Announced, accessed on November 9, 2026.
  8. 8Encyclopedia.com, Benoit B. Mandelbrot, accessed on November 9, 2026.
  9. 9Encyclopedia.com, Brenner, Sydney, accessed on November 9, 2026.
  10. 10The Jerusalem Post, 'Nobel Prize predictor': 20% of Technion's Harvey Prize winners receive Nobel, accessed on November 9, 2026.
  11. 11Encyclopedia.com, Dyson, Freeman J. 1923- (Freeman Dyson, Freeman John Dyson), accessed on November 9, 2026.
  12. 12Encyclopedia.com, Lewis, Bernard 1916-, accessed on November 9, 2026.
  13. 13Encyclopaedia Britannica, accessed on November 9, 2026.
  14. 14Encyclopedia.com, Aumann, Robert J. 1930–, accessed on November 9, 2026.
  15. 15Encyclopaedia Britannica, accessed on November 9, 2026.
  16. 16Jewish Virtual Library, Drew Weissman, accessed on November 9, 2026.
  17. 17The Jerusalem Post, Technion Harvey prize in science awarded to Israeli, American professors, accessed on November 9, 2026.
  18. 18Ynet, The Technion Will Award the Harvey Prize to 3 Researchers in the Field of Cancer Epigenetics, accessed on November 9, 2026.

IsraelPedia Question & Answers

  • What is the Harvey Prize?

    The Harvey Prize is an annual award presented by the Technion–Israel Institute of Technology in Haifa for outstanding achievements in science, technology, and human health, and for significant contributions to humanity. Its awards have also recognized contributions to peace and society, as well as Jewish scholarship.

  • Who established the Harvey Prize, and when was it first awarded?

    Industrialist and inventor Leo Harvey established the Harvey Prize, which was first awarded in 1972. Accounts differ on its establishment year: some place it in 1971, while a 2026 report says Harvey established it in 1972, the year of the first award.

  • What fields and contributions does the Harvey Prize recognize?

    The Harvey Prize recognizes achievements in science and technology, human health, and service to humanity. Its scope has also included breakthroughs contributing to peace in the Middle East and contributions to society. Recipients have included scientists, a Talmud scholar, and a philanthropist, diplomat, entrepreneur, and arts patron.

  • How did the Harvey Prize–winning mRNA research contribute to COVID-19 vaccines?

    Katalin Karikó and Drew Weissman developed nucleoside-modified mRNA that suppressed inflammatory responses to mRNA molecules, opening the way to RNA-based therapeutics. Pieter R. Cullis developed lipid nanoparticles that protect mRNA and transport it into cells. Their work enabled the rapid development and delivery of effective COVID-19 vaccines, and the technology became a foundational component of the Pfizer/BioNTech and Moderna vaccines in 2020.

  • Why is the Harvey Prize called a “Nobel predictor”?

    Several Harvey Prize recipients later received Nobel Prizes, giving the award a reputation as a “Nobel predictor.” Published estimates differ: a 2026 account put the proportion at approximately 20%, while a 2023 account said more than 30%. Shoji Nakamura received the Harvey Prize for inventing the blue LED five years before sharing the 2014 Nobel Prize in Physics for that invention.